Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes

Impact · against what's priced in

The appointment of Nir Naor as CFO provides a positive catalyst for STIM, as he brings a specific track record of driving medtech companies to profitability and cash flow positivity within a year. While the departure of the Chief Legal Officer is a slight negative, the overall management shake-up signals a shift toward operational rigor and margin expansion.

STIM+0.50

No priced-in read yet